Opa1 relies on cristae preservation and ATP synthase to curtail reactive oxygen species accumulation in mitochondria.


Journal

Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639

Informations de publication

Date de publication:
05 2021
Historique:
received: 08 01 2021
revised: 26 02 2021
accepted: 10 03 2021
pubmed: 30 3 2021
medline: 6 7 2021
entrez: 29 3 2021
Statut: ppublish

Résumé

Reactive oxygen species (ROS) are a common product of active mitochondrial respiration carried in mitochondrial cristae, but whether cristae shape influences ROS levels is unclear. Here we report that the mitochondrial fusion and cristae shape protein Opa1 requires mitochondrial ATP synthase oligomers to reduce ROS accumulation. In cells fueled with galactose to force ATP production by mitochondria, cristae are enlarged, ATP synthase oligomers destabilized, and ROS accumulate. Opa1 prevents both cristae remodeling and ROS generation, without impinging on levels of mitochondrial antioxidant defense enzymes that are unaffected by Opa1 overexpression. Genetic and pharmacologic experiments indicate that Opa1 requires ATP synthase oligomerization and activity to reduce ROS levels upon a blockage of the electron transport chain. Our results indicate that the converging effect of Opa1 and mitochondrial ATP synthase on mitochondrial ultrastructure regulate ROS abundance to sustain cell viability.

Identifiants

pubmed: 33780775
pii: S2213-2317(21)00092-6
doi: 10.1016/j.redox.2021.101944
pmc: PMC8039725
pii:
doi:

Substances chimiques

Mitochondrial Proteins 0
Reactive Oxygen Species 0
Adenosine Triphosphate 8L70Q75FXE
GTP Phosphohydrolases EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101944

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Rubén Quintana-Cabrera (R)

Institute of Functional Biology and Genomics (IBFG), University of Salamanca, CSIC, Salamanca, Spain; Institute of Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, University of Salamanca, CSIC, Salamanca, Spain; CIBERFES, Institute of Health Carlos III, Madrid, Spain; Department of Biochemistry and Molecular Biology, University of Salamanca, Spain. Electronic address: ruben310@usal.es.

Israel Manjarrés-Raza (I)

Institute of Functional Biology and Genomics (IBFG), University of Salamanca, CSIC, Salamanca, Spain; Institute of Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, University of Salamanca, CSIC, Salamanca, Spain; CIBERFES, Institute of Health Carlos III, Madrid, Spain; Department of Biochemistry and Molecular Biology, University of Salamanca, Spain.

Carlos Vicente-Gutiérrez (C)

Institute of Functional Biology and Genomics (IBFG), University of Salamanca, CSIC, Salamanca, Spain; Institute of Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, University of Salamanca, CSIC, Salamanca, Spain; CIBERFES, Institute of Health Carlos III, Madrid, Spain.

Mauro Corrado (M)

Department of Immunometabolism, Max Planck Institute of Epigenetics and Immunobiology, Freiburg Im Breisgau, Germany.

Juan P Bolaños (JP)

Institute of Functional Biology and Genomics (IBFG), University of Salamanca, CSIC, Salamanca, Spain; Institute of Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, University of Salamanca, CSIC, Salamanca, Spain; CIBERFES, Institute of Health Carlos III, Madrid, Spain; Department of Biochemistry and Molecular Biology, University of Salamanca, Spain.

Luca Scorrano (L)

Veneto Institute of Molecular Medicine, Padova, Italy; Department of Biology, University of Padova, Padova, Italy. Electronic address: luca.scorrano@unipd.it.

Articles similaires

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia.

Lisa Demoen, Filip Matthijssens, Lindy Reunes et al.
1.00
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Animals Mice Humans Cell Line, Tumor
Adenosine Triphosphate Adenosine Diphosphate Mitochondrial ADP, ATP Translocases Binding Sites Mitochondria
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Classifications MeSH